The use of hyphenated LC-MS technique for characterisation of impurity profiles during drug development

Journal of Pharmaceutical and Biomedical Analysis

Volumn 18, Issue 4-5, 1998, Pages 707-714

  Ermer, Joachim ^a  

^a SANOFI   (France)

Author keywords

Impurity profile; Impurity qualification; LC MS; Multidimensional; On line coupling; Quality control

Indexed keywords

GONADORELIN ANTAGONIST; RAMORELIX; UNCLASSIFIED DRUG;

ARTICLE; DRUG CONTROL; DRUG DEVELOPMENT; DRUG IMPURITY; DRUG PURITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; DRUG CONTAMINATION; DRUG DESIGN; MASS SPECTROMETRY; OLIGOPEPTIDES;

EID: 0032442442     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(98)00267-2     Document Type: Article

References (11)

1. International Conference on the Harmonization of the Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Q3A: Impurities in New Drug Substances (adopted March 1995).
2. ICH, Q3B: Impurities in New Drug Products (adopted July 1997).
3. ICH, Q3C: Impurities: Residual Solvents (Step 4, July 1997).
4. ICH, Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances.
5. J. Ermer, H. Möller, Regul. Aff. J. 8 (1997) 722-729.
6. J. Ermer, P.-G. Kibat, Pharm. Sci. Technol. Today 1 (1998) 76-82.
7. B.A. Olsen, S.W. Baertschi, R.M. Riggin, J. Chromatogr. 648 (1993) 165-173.
8. J.D. Gilbert, T.V. Ohla, D.A. McLaughlin, in: A.P. Snyder (Ed.), ACS Symposium Series 619, American Chemical Society, Washington, DC, 1995, pp. 330-350.
9. X. Xiang, C.Y. Ko, H.Y. Guh, Anal.Chem. 68 (1996) 3726-3731.
10. A. Casazza, O. Curcuruto, M. Hamdan, A. Bisello, E. Peggion, J. Chromatogr. A 715 (1995) 227-240.
11. G.J. Opiteck, K. c. Lewis, J.W. Jorgenson, Anal.Chem. 69 (1997) 1518-1524.